KATELYN DURLER: Open Payments
NPI 1053068114 · DODGE CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 46 payments from 14 companies in 2025. Trend: 2023 $806 · 2024 $1,018 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $438 |
| Novo Nordisk Inc | 13 | $214 |
| Lilly USA, LLC | 8 | $125 |
| PFIZER INC. | 5 | $76 |
| ABBVIE INC. | 3 | $48 |
| Dexcom, Inc. | 1 | $28 |
| Exact Sciences Corporation | 2 | $28 |
| Merck Sharp & Dohme LLC | 2 | $28 |
| Seqirus USA Inc | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: FARXIGA, AIRSUPRA, MOUNJARO, Ozempic, NURTEC ODT, Rybelsus, Wegovy, VRAYLAR.
Industry payments across KS — which companies pay providers there.
